The CBFB gene helps control how other genes switch on as cells grow and mature, especially in blood-forming cells and cells involved in building bone. If it does not work properly, these cells may not develop in the usual way. Some variants in this gene are linked to certain blood cancers, and some can affect normal growth and development. Most people learn about the CBFB gene through genetic testing done during cancer care or when a developmental condition is being investigated.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes hold the directions for producing proteins, which are the parts of cells that do much of the work. Other genes mainly help decide when certain processes occur, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medicines. For a closer look at this topic, you can learn more in the LearnHub.
Overview
CBFBGene function
What if the gene works
The CBFB gene helps control how other genes are used. This supports normal blood cell formation and healthy bone development.
Risk
What if the gene does not work
Changes in the CBFB gene can affect bone growth and brain development, causing developmental delay, learning difficulties, and skeletal differences. Effects can range from milder to more severe depending on the variant. Acquired CBFB rearrangements are also linked to leukemia.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the CBFB gene, no CBFB-specific treatment or drug selection approach is currently established. In cancer care, the CBFB::MYH11 fusion is a well-established biomarker in a subtype of acute myeloid leukemia and can help guide chemotherapy planning and disease monitoring, but the CBFB gene itself is not a direct drug target.
Conditions associated with CBFB
Gene function
What if the gene works
Your cells use the CBFB gene to help other proteins control when many genes are turned on or off. It acts as a steady partner for RUNX proteins, which guide cell growth, timing, and specialization. Understanding what the CBFB gene does in the body helps explain how blood, bone, and other tissues develop in an organized way.
The CBFB gene helps RUNX proteins manage when other genes are active. This gives cells clear instructions for growth, division, and maturing into their planned cell type.
Its protein does not usually bind DNA on its own. Instead, it attaches to RUNX proteins and helps them hold on to DNA more securely, so gene signals stay steady.
By supporting RUNX signals, the CBFB gene helps developing cells follow the right timing as tissues form and renew. This is especially important in blood-forming cells and in cells that build and maintain bone.
What is a variant?
A genetic variant is a minor alteration in the DNA sequence within a gene. These changes are common and help explain normal differences among people, including appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not produce any noticeable effect and are part of natural genetic diversity. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CBFB gene can weaken the protein made from this gene, make it unstable, or reduce how well it binds RUNX partner proteins that help control other genes. Truncating, splice, or deletion variants often leave little or no working protein, while some missense variants cause a partial loss of function. This explains how CBFB gene variants affect protein function across a spectrum from milder to more severe changes, which can influence how strongly cell regulation is disrupted.
How variants are linked to conditions
Rare pathogenic variants of the CBFB gene can cause a skeletal condition similar to cleidocranial dysplasia, with delayed skull closure, dental differences, and underdeveloped collarbones. Separately, acquired changes involving the CBFB gene, especially the CBFB::MYH11 fusion, are a well-established finding in some cases of acute myeloid leukemia. These are distinct situations, and common inherited variants in the CBFB gene do not reliably predict leukemia.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely seen across the general population. Most do not directly affect health and instead represent natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors also contribute. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CBFB gene. If you have a CBFB change on testing or a family history that worries you, a doctor or genetic counselor can help explain what it may mean for your personal risk.
Inheritance of CBFB variants
CBFB-related conditions that are caused by a disease-causing variant in the CBFB gene are inherited in an autosomal dominant pattern. This means a parent carrying the variant has a 50% chance in each pregnancy of passing it to a child. In families learning how CBFB gene variants are inherited, it also helps to know that some people have a new, de novo variant that was not inherited from either parent. Once present, the variant can then be passed on to future children.
What does my CBFB result mean for my family?
For the inherited condition linked to the CBFB gene, the pattern is typically dominant, which means close relatives such as parents, brothers, sisters, and children may also carry the same change and may want to discuss testing. In some families, the gene change starts new in one person, so it is not always inherited from a parent. The exact meaning for relatives depends on whether the result is an inherited CBFB change or a gene change found only in cancer cells.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the CBFB gene, CBFB genetic testing uses a blood or saliva sample. A lab reads the gene's DNA code and may also check for missing or extra pieces, helping show whether a variant is present.
When should I consider getting a genetic test?
Genetic testing for the CBFB gene may be worth considering when a child has signs of a rare inherited condition affecting bone growth and development, such as unusual skull or collarbone development, delayed teeth, short stature, or developmental delay. It can also help when similar features run in the family.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it can tell you varies by the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, also affect how the body functions. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as response to medications, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to its effects at the target tissue. This is a common reason why the same medication may work well for one person, seem less helpful for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore this subject further, you can learn more in the LearnHub.
Drugs influenced by the CBFB gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or dosed. If you have concerns about a medication, side effects, or changes in your health, speak with your doctor.
History
CBFB entered medical genetics through research on blood cancers in the late 20th century, especially acute myeloid leukemia with a chromosome change called inv(16). In the 1990s, researchers showed that this chromosome rearrangement joins the CBFB gene to MYH11, helping define a distinct leukemia subtype. From these first observations, research expanded steadily. That discovery became an important step in cancer genetics because it linked a specific gene change to diagnosis, classification, and disease monitoring. Over time, the CBFB gene also became relevant in studies of inherited bone conditions, broadening interest beyond leukemia. Today, its history is mainly tied to how chromosome studies and gene testing transformed the understanding of certain cancers.